Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis.

Grosios, K

Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis. [electronic resource] - Inflammation research : official journal of the European Histamine Research Society ... [et al.] Apr 2004 - 133-42 p. digital

Publication Type: Journal Article

1023-3830

10.1007/s00011-003-1230-4 doi


Angiogenesis Inhibitors--pharmacology
Animals
Arthritis, Rheumatoid--drug therapy
Collagen--immunology
Female
Hyperalgesia--drug therapy
Male
Mice
Mice, Inbred DBA
Phthalazines--pharmacology
Pyridines--pharmacology
Rats
Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors